Lowes Companies Inc
—- Market cap
- $111.31B
- Debt
- —
- Cash
- −$982.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $111.31B · View financials
Snapshot Sep 11, 2026, 12:38 PM ET
Decision snapshot: LOW stock price near parity vs BMY $198.39 current versus $217.24 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMY's multiple
Implied fair value · at LOW's multiple
Snapshot Sep 11, 2026, 12:38 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
14 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 74% equity / 26% debt · EV / Revenue 3.41x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
LOWES COMPANIES INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
BRISTOL-MYERS SQUIBB COMPANY · implied price per share
Bear
$59.11
Base
$72.93
Bull
$92.88
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HOME DEPOT, INC.
LOW vs HD
SHERWIN WILLIAMS CO
LOW vs SHW
WILLIAMS SONOMA INC
LOW vs WSM
Tractor Supply Company
LOW vs TSCO
Pfizer Inc.
LOW vs PFE
Merck & Co., Inc.
LOW vs MRK
AbbVie Inc.
LOW vs ABBV
Eli Lilly and Company
LOW vs LLY
Amgen Inc.
LOW vs AMGN
Gilead Sciences, Inc.
LOW vs GILD
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.